Industry Overview
The Global Cold Plasma Market is likely to be valued at USD 1.3 billion in 2023 and is anticipated to attain USD 3.6 billion by 2030, developing at a CAGR of 12.5% concurrently for the forecast duration (by 2030). Cold plasma, also known as non-thermal plasma, is an innovative concept with extensive adoption in medical device applications. Various medical disciplines, such as cardiology, dermatology, gastroenterology, and oncology, have benefited from the technology, which is now widely utilized to aid surgery in these fields.The cold plasma technology has gained significant attention in the healthcare industry due to its potential applications in various medical fields. Cold plasma refers to a partially ionized gas that is produced at atmospheric pressure and low temperatures. It consists of a mixture of ions, electrons, reactive oxygen species, and other free radicals.
.jpg "Cold Plasma in Healthcare Market Highlights")
Cold plasma offers a wide range of uses in bioengineering and as an antibacterial treatment for food processing along with increased adoption of cold plasma in wound healing, which is boosting the cold plasma market in the healthcare sector forward. The novel adoption of cold plasma in cancer therapy is an intriguing field that is predicted to have a substantial impact on current cancer therapeutic research, propelling the cold plasma market forward.
Cold Plasma in Healthcare Market Segmentation
Insight by Regime Type
Based on the regime, the cold plasma in the healthcare market is divided into low-pressure cold plasma and atmospheric cold plasma. The atmospheric cold plasma dominates the market as it kills microbes without harming human tissues. Atmospheric Cold Plasma (ACP) is a technique that increases molecules, atoms, and ions' natural processes. Furthermore, it aids in treating cancer patients owing to its anti-tumour properties.
Insight by Application
Based on application, the cold plasma in the healthcare market is divided into wound healing, blood coagulation, dentistry, cancer treatment, and others. The wound healing segment dominates the cold plasma market as cold plasma can kill bacteria, including drug-resistant bacteria, and thus aids in the treatment of chronic wounds by preventing infection. It also hastens the wound healing process and prevents additional complications.
Moreover, with the rising incidences of road traffic injuries, resulting in a large number of patients suffering from traumas and increased wound management cases, the implementation of cold plasma is anticipated to grow for wound healing in hospitals and healthcare facilities. Furthermore, the rising geriatric population having diabetes may have chronic wounds like foot ulcers, thus accelerating the growth of cold plasma in the healthcare market. Although many alternative wound healing therapy processes exist, cold plasma treatment is expected to be one of the most successful strategies to propel the overall segment forward.
Global Cold Plasma in Healthcare Market Report Coverage
|
Report Metric
|
Details
|
|
Historical Period
|
2018 - 2023
|
|
Base Year Considered
|
2024
|
|
Forecast Period
|
2025 - 2030
|
|
Market Size in 2024
|
U.S.D. 1.3 Billion
|
|
Revenue Forecast in 2030
|
U.S.D. 3.68 Billion
|
|
Growth Rate
|
12.5%
|
|
Segments Covered in the Report
|
By Regime Type, and By Application
|
|
Report Scope
|
Market Trends, Drivers, and Restraints; Revenue Estimation and Forecast; Segmentation Analysis; Impact of COVID-19; Companies’ Strategic Developments; Market Share Analysis of Key Players; Company Profiling
|
|
Regions Covered in the Report
|
North America, Europe, Asia-Pacific, Middle East, and Rest of the World
|
Industry Dynamics
Cold Plasma in Healthcare Market Growth Drivers
Cold plasma in the healthcare market is extensively used in medicinal and bioengineering fields. They are used to sanitize biomedical surfaces and treat natural tissues because of their antibacterial and bacterial characteristics. Cold plasma treatments have shown the potential to cure a variety of growth types, including lung, cerebrum, breast, and skin. The evolving applications in life sciences like treating surgical and traumatic wounds and increased commercialization will drive the growth of cold plasma in the healthcare market.
Antimicrobial Applications: Cold plasma has shown promising antimicrobial properties, effectively killing bacteria, viruses, and fungi. It can be used to sterilize medical instruments, disinfect surfaces, and treat contaminated water. The technology has the potential to reduce hospital-acquired infections and improve overall hygiene in healthcare facilities.
Wound Healing: Cold plasma has been studied for its ability to promote wound healing. When applied to wounds, it can stimulate cell migration, accelerate tissue regeneration, and reduce inflammation. It shows promise in treating chronic wounds, burns, and ulcers, providing an alternative to conventional wound care methods.
Cancer Treatment: Cold plasma has shown potential in cancer therapy, primarily through its ability to induce apoptosis (programmed cell death) in cancer cells. Researchers are exploring its use in targeted cancer therapies, including the treatment of skin cancer, breast cancer, and lung cancer. However, further research is needed to establish its efficacy and safety.
Cold Plasma in Healthcare Market Challenges
Cold plasma techniques are capital-intensive as the equipment necessary for operation, like vacuum equipment, is expensive and requires unique operating circumstances, such as low temperatures and regulated vacuum settings, resulting in hampering the growth of the cold plasma market.
Cold Plasma in Healthcare Market Opportunities
Cold plasma's improved efficacy in developing therapies for various forms of cancer, like lung, breast, bladder, and skin, is likely to open up numerous opportunities for the market participants during the projected period. The cold plasma technique has been proven to selectively kill cancer cells in a variety of in vitro and in vivo investigations. Plasma-induced apoptosis and the reduction of cell migratory velocity are two key properties that have improved the usage of cold plasma in cancer therapy. This aids in the localization of the damaged tissue area as well as the prevention of cancer metastasis.
Cold plasma can also be used in conjunction with chemotherapy to increase wound sterilizing, blood coagulation, and cell proliferation during wound healing. Its use enables successful medical treatment of cancer, as well as a variety of skin injuries and disorders.
Recent Developments By the Key Players
Wacker Chemie AG this week started up two new production facilities for specialty silicones in Japan.
Cold Plasma in Healthcare Market Geographic Overview
North America contributes to the largest share in the cold plasma healthcare market owing to the presence of key industry players and the increased number of products having FDA approvals. Moreover, the increased adoption of technologically developed products will further accelerate the growth of cold plasma in the healthcare market in the region. There is an increased demand for plasma therapy owing to the rising cases of coronavirus.
Cold Plasma in Healthcare Market Competitive Insight
In the healthcare market, cold plasma is consolidated in nature with players strategizing via research and development activities, partnerships, agreements, collaborations, alliances, M&A, product development, etc. to expand their geographical presence and sustain themselves in the market.
Some of the leading businesses in the cold plasma healthcare sector are :
The Cold Plasma in Healthcare Market report offers a comprehensive market segmentation analysis along with an estimation for the forecast period 2025–2030.
Segments Covered in the Report
- By Regime Type
- Low Pressure
- Atmospheric Pressure
- By Application
- Wound Healing
- Cancer Treatment
- Dentistry
- Blood Coagulation
- Others
Region Covered in the Report
- North America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia-Pacific (APAC)
- China
- Japan
- India
- South Korea
- Rest of Asia-Pacific
- Rest of the World (RoW)
- Brazil
- Saudi Arabia
- South Africa
- U.A.E.
- Other Countries
.png "Cold Plasma in Healthcare Market Size and Market Analysis")
